Mineralys Therapeutics, Inc. - COMMON STOCK (MLYS)

CUSIP: 603170101

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 6 signals
Share change
+572,700
SEC-reported price per share
$17.05
Number of holders
68
Value change
+$10,759,767
Number of buys
42
Number of sells
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
87,484,107

Security key

603170101

Report period

Q2 2023

Institutions

68

Top holders

10

Ownership snapshot

Top reported holders of MLYS - Mineralys Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
HBM Healthcare Investment...
Disclosed value leader
Samsara BioCapital, LLC
Comparable rows
0/15
Latest evidence
31 Mar 2023
3/4/5 13F Highest disclosed value: $70,773,193 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Samsara BioCapital, LLC has the largest disclosed position value at $70.77M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Samsara BioCapital, LLC's linked filing trail.
Disclosed position value Top 5
HBM Healthcare Investments (Cayma... $19.2M
Samsara BioCapital, LLC $70.77M
RA CAPITAL MANAGEMENT, L.P. $49.77M
ADAMS STREET PARTNERS LLC $37.89M
SR ONE CAPITAL MANAGEMENT, LP $28.1M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
HBM Healthcare Investments (Cayman) Ltd.
3/4/5
10%+ Owner
—
denominator unverified
$19,199,542
3,218,106 shares
— 14 Feb 2023
Samsara BioCapital, LLC
13F
Company
13F
—
denominator unverified
$70,773,193
4,519,361 shares
— 31 Mar 2023
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$49,774,934
3,178,476 shares
— 31 Mar 2023
ADAMS STREET PARTNERS LLC
13F
Company
13F
—
denominator unverified
$37,889,385
2,419,501 shares
— 31 Mar 2023
SR ONE CAPITAL MANAGEMENT, LP
13F
Company
13F
—
denominator unverified
$28,103,436
1,794,600 shares
— 31 Mar 2023
Avidity Partners Management LP
13F
Company
13F
—
denominator unverified
$19,791,108
1,263,800 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
68
Shares
25,186,898
Rows available
68
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
66
Q2 2023 holders
68
Holder diff
2
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .